Interleukin-10 and Interleukin-1β Cytokines Expression in Leukocytes of Patients with Chronic Peri-Mucositis

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2019 Oct 6

PMID 31586435

Citations 4

Authors

Darius Gleiznys

Alvydas Gleiznys

Lina Abraskeviciute

Astra Vitkauskiene

Viktoras Saferis

Jurgina Sakalauskiene

Affiliations

Soon will be listed here.

Abstract

BACKGROUND The purpose of the present research is to analyze the effect of polyphenols and flavonoids substrat (PFS) from plants Calendula officinalis, Salvia fruticosa, Achillea millefolium, and propolis as immunomodulatory in the production of interleukin (IL)-1ß and IL-10 in peripheral blood leukocytes medium (PBLM) in patients who were diagnosed with mucositis of peri-implant tissue compared to patients with healthy implant tissue. It was hypothesized that IL-1ß and IL-10 contribute to the inflammation processes noticed in the diseases of peri-implant tissues. MATERIAL AND METHODS Sixty non-smoking patients were included in this study: patients with healthy implants (HP group) and patients with peri-implant mucositis (MP group). Peri-mucositis was diagnosed by radiologic and clinical examination. The PBLM from MP were treated with PFS at various concentrations. The levels of IL-10 and IL-1ß excreted by the PBLM stimulated and unstimulated with viable Porphyromonas gingivalis test-tube were committed by the enzyme amplified immunoassay sensitivity method. RESULTS Unstimulated and stimulated PBLM and treatment with 5.0 mg/mL or 10.0 mg/mL of PFS in the MP group produced significantly higher levels IL-10 (P<0.001) that analogous mediums of the HP group. The levels of IL-1ß decreased more considerably in the stimulated PBLM of the MP group than in those of HP group (P<0.001) after the treatment with PFS at only 10.0 mg/mL concentration. CONCLUSIONS Theses results suggest that the solution of PFS might offer a new potential for the development of a new therapeutic path to prevent and treat peri-implant mucositis.

Citing Articles

A Comparative Analysis of the Efficacy of Bacterial Lysate versus Antibiotic Therapy in the Treatment of Experimental Peri-Implantitis in Rats.

Ancuta D, Alexandru D, tucureanu C, Coman C Microorganisms. 2024; 12(8).

PMID: 39203379 PMC: 11356466. DOI: 10.3390/microorganisms12081537.

Chemical Profiling and Antioxidant and Anti-Amyloid Capacities of Extracts from Greece.

Ververis A, Kyriakou S, Ioannou K, Chatzopoulou P, Panayiotidis M, Plioukas M Plants (Basel). 2023; 12(18).

PMID: 37765357 PMC: 10535607. DOI: 10.3390/plants12183191.

Current Molecular, Cellular and Genetic Aspects of Peri-Implantitis Disease: A Narrative Review.

Chmielewski M, Pilloni A Dent J (Basel). 2023; 11(5).

PMID: 37232785 PMC: 10217441. DOI: 10.3390/dj11050134.

Interleukin-16 rs4072111 Polymorphism is Associated with the Risk of Peri-Implantitis in the Chinese Population.

Chen Z, Chen G Pharmgenomics Pers Med. 2021; 14:1629-1635.

PMID: 34938097 PMC: 8686223. DOI: 10.2147/PGPM.S336857.

References

Fonseca F, Moraes Junior M, Lourenco E, Teles D, Figueredo C . Cytokines expression in saliva and peri-implant crevicular fluid of patients with peri-implant disease. Clin Oral Implants Res. 2012; 25(2):e68-72. DOI: 10.1111/clr.12052. View

Delima A, Oates T, Assuma R, Schwartz Z, Cochran D, Amar S . Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol. 2001; 28(3):233-40. DOI: 10.1034/j.1600-051x.2001.028003233.x. View

Petkovic-Curcin A, Matic S, Vojvodic D, Stamatovic N, Todorovic T . Cytokines in pathogenesis of peri-implantitis. Vojnosanit Pregl. 2011; 68(5):435-40. DOI: 10.2298/vsp1105435p. View

Ataoglu H, Alptekin N, Haliloglu S, Gursel M, Ataoglu T, Serpek B . Interleukin-1beta, tumor necrosis factor-alpha levels and neutrophil elastase activity in peri-implant crevicular fluid. Clin Oral Implants Res. 2002; 13(5):470-6. DOI: 10.1034/j.1600-0501.2002.130505.x. View

Passoja A, Puijola I, Knuuttila M, Niemela O, Karttunen R, Raunio T . Serum levels of interleukin-10 and tumour necrosis factor-α in chronic periodontitis. J Clin Periodontol. 2010; 37(10):881-7. DOI: 10.1111/j.1600-051X.2010.01602.x. View

Dong C . Differentiation and function of pro-inflammatory Th17 cells. Microbes Infect. 2009; 11(5):584-8. PMC: 2698049. DOI: 10.1016/j.micinf.2009.04.001. View

Mulligan M, Warner R, McDuffie J, Bolling S, Sarma J, Ward P . Regulatory role of Th-2 cytokines, IL-10 and IL-4, in cardiac allograft rejection. Exp Mol Pathol. 2000; 69(1):1-9. DOI: 10.1006/exmp.2000.2304. View

Crome S, Wang A, Levings M . Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol. 2009; 159(2):109-19. PMC: 2810379. DOI: 10.1111/j.1365-2249.2009.04037.x. View

Jepsen S, Berglundh T, Genco R, Aass A, Demirel K, Derks J . Primary prevention of peri-implantitis: managing peri-implant mucositis. J Clin Periodontol. 2015; 42 Suppl 16:S152-7. DOI: 10.1111/jcpe.12369. View

10.

Nagaoka T, Banskota A, Tezuka Y, Midorikawa K, Matsushige K, Kadota S . Caffeic acid phenethyl ester (CAPE) analogues: potent nitric oxide inhibitors from the Netherlands propolis. Biol Pharm Bull. 2003; 26(4):487-91. DOI: 10.1248/bpb.26.487. View

11.

Surh Y . NF-kappa B and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities. Asia Pac J Clin Nutr. 2008; 17 Suppl 1:269-72. View

12.

Isola G, Matarese M, Ramaglia L, Iorio-Siciliano V, Cordasco G, Matarese G . Efficacy of a drug composed of herbal extracts on postoperative discomfort after surgical removal of impacted mandibular third molar: a randomized, triple-blind, controlled clinical trial. Clin Oral Investig. 2018; 23(5):2443-2453. DOI: 10.1007/s00784-018-2690-9. View

13.

Okada H, Murakami S . Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med. 1998; 9(3):248-66. DOI: 10.1177/10454411980090030101. View

14.

Kornman K, Page R, Tonetti M . The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000. 1997; 14:33-53. DOI: 10.1111/j.1600-0757.1997.tb00191.x. View

15.

Lang N, Berglundh T . Periimplant diseases: where are we now?--Consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol. 2011; 38 Suppl 11:178-81. DOI: 10.1111/j.1600-051X.2010.01674.x. View

16.

Hoene A, Patrzyk M, Walschus U, Finke B, Lucke S, Nebe B . Systemic IFNγ predicts local implant macrophage response. J Mater Sci Mater Med. 2015; 26(3):131. DOI: 10.1007/s10856-015-5476-5. View

17.

Casado P, Canullo L, de Almeida Filardy A, Granjeiro J, Porto Barboza E, Duarte M . Interleukins 1β and 10 expressions in the periimplant crevicular fluid from patients with untreated periimplant disease. Implant Dent. 2013; 22(2):143-50. DOI: 10.1097/ID.0b013e3182818792. View

18.

Casado P, Pereira M, Duarte M, Granjeiro J . History of chronic periodontitis is a high risk indicator for peri-implant disease. Braz Dent J. 2013; 24(2):136-41. DOI: 10.1590/0103-6440201302006. View

19.

Basch E, Bent S, Foppa I, Haskmi S, Kroll D, Mele M . Marigold (Calendula officinalis L.): an evidence-based systematic review by the Natural Standard Research Collaboration. J Herb Pharmacother. 2007; 6(3-4):135-59. DOI: 10.1080/j157v06n03_08. View

20.

Preethi K, Kuttan G, Kuttan R . Anti-inflammatory activity of flower extract of Calendula officinalis Linn. and its possible mechanism of action. Indian J Exp Biol. 2009; 47(2):113-20. View